Sure, that's bad. There's no point spending money chasing existing stock of the drug within the country, if it's useful it will all get used anyway.

But a $100M or whatever check to ramp up production, or to buy wholesale stock from elsewhere, that would have been worth writing on day 1. Even on extremely flimsy evidence, given the huge daily costs of this thing. Run the careful trials at the same time as building a huge factory which you probably won't need.